SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001104659-21-105231
Filing Date
2021-08-13
Accepted
2021-08-13 17:10:06
Documents
4
Effectiveness Date
2021-08-13

Document Format Files

Seq Description Document Type Size
1 S-8 POS tm2124861d3_s8pos.htm S-8 POS 50462
2 EXHIBIT 5.1 tm2124861d3_ex5-1.htm EX-5.1 11219
3 EXHIBIT 23.1 tm2124861d3_ex23-1.htm EX-23.1 2106
4 GRAPHIC tm2124861d3_ex5-1img001.jpg GRAPHIC 10415
  Complete submission text file 0001104659-21-105231.txt   79431
Mailing Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DR STE 300 ROCKVILLE MD 20850 240-864-2600
CASI Pharmaceuticals, Inc. (Filer) CIK: 0000895051 (see all company filings)

IRS No.: 581959440 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-188042 | Film No.: 211173288
SIC: 2836 Biological Products, (No Diagnostic Substances)